These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12470304)

  • 21. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinic discharge of schizophrenic patients: treatment termination or transition? A catamnestic study of community psychiatric management].
    Hell D; Zingg P
    Psychiatr Prax; 1991 Nov; 18(6):202-8. PubMed ID: 1771201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TAPS Project. 22: A five-year follow-up of long-stay psychiatric patients discharged to the community.
    Leff J; Thornicroft G; Coxhead N; Crawford C
    Br J Psychiatry Suppl; 1994 Nov; (25):13-7. PubMed ID: 7865192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A national study of violent behavior in persons with schizophrenia.
    Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up study.
    Ritsner M; Ratner Y; Gibel A; Weizman R
    Psychiatry Res; 2005 Sep; 136(2-3):173-9. PubMed ID: 16098602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ego-pathology, body experience, and body psychotherapy in chronic schizophrenia.
    Röhricht F; Papadopoulos N; Suzuki I; Priebe S
    Psychol Psychother; 2009 Mar; 82(Pt 1):19-30. PubMed ID: 18789189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Pharmacopsychiatry; 2007 Nov; 40(6):269-74. PubMed ID: 18030651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
    Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
    Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study.
    Reichenberg A; Rieckmann N; Harvey PD
    J Abnorm Psychol; 2005 Aug; 114(3):363-72. PubMed ID: 16117573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical dimensions of auditory hallucinations in schizophrenic disorders.
    Oulis P; Gournellis R; Konstantakopoulos G; Matsoukas T; Michalopoulou PG; Soldatos C; Lykouras L
    Compr Psychiatry; 2007; 48(4):337-42. PubMed ID: 17560954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive treatment models and coercion.
    Ohlenschlaeger J; Thorup A; Petersen L; Jeppesen P; Køster A; Munkner R; Nordentoft M
    Nord J Psychiatry; 2007; 61(5):369-78. PubMed ID: 17990199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The negative syndrome as a dimension: factor analyses of PANSS in major depressive disorder and organic brain disease compared with negative syndrome structures found in the schizophrenia literature.
    Milak MS; Aniskin DB; Eisenberg DP; Prikhojan A; Cohen LJ; Yard SS; Galynker II
    Cogn Behav Neurol; 2007 Jun; 20(2):113-20. PubMed ID: 17558255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of a coordinated management program on the outcome of a cohort of ambulatory psychiatric patients].
    Huguelet P; Vogel S; Lusti O; Favrod J; Gonzalez C
    Encephale; 1997; 23(4):257-61. PubMed ID: 9417390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Schizophrenia, from classification to dimensions: value of longitudinal studies].
    Lecrubier Y
    Encephale; 1997 Apr; 23 Spec No 2():39-43. PubMed ID: 9273306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Syndrome and symptom development in long-term follow-up of schizophrenia].
    Franzek E; Beckmann H
    Nervenarzt; 1991 Sep; 62(9):549-56. PubMed ID: 1956474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subgroups and Prognosis of "Difficult-to-Place" Schizophrenic Long-Stay Patients: Distinguishing "Hard Core" Patients].
    Meyer T; Franz M; Gallhofer B
    Psychiatr Prax; 2002 Sep; 29(6):301-5. PubMed ID: 12224039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community care and need for treatment of schizophrenic patients in Finland.
    Salokangas RK
    Br J Psychiatry Suppl; 1994 Apr; (23):115-20; discussion 121-2. PubMed ID: 8037895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.